BioIndustry Association | BIA

Member login

Discover the benefits of BIA membership

Member Benefits

Scroll for more

.

22 Apr 24

Blog

Step up and create more inclusive workplaces within the biotech sector

03 May 24

Press releases

BIA teams up with top UK engineering biology stakeholders to champion the UK at SynBioBeta

09 May 24

Blog

A critical time for AI, dementia and better brain health

09 Apr 24

Press releases

Post-Brexit border paperwork and inspections postponed for life sciences sector

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence policymakers

Influence

policymakers, ensuring your voice is heard on matters that are critical to the success of your organisation

Connect at BIA events

Connect

with the UK ecosystem through industry-leading events, expert committees and overseas missions

Save

Save

money with the BIA Business Solutions purchasing programme, helping your business grow cost-effectively

Biotech and life sciences news and insights

View all news

03 May 24

Press releases

BIA teams up with top UK engineering biology stakeholders to champion the UK at SynBioBeta 2024

BIA is gearing up for a prominent presence at SynBioBeta 2024, the world's leading conference for engineering biology. The BIA is leading a coalition of UK stakeholders to showcase the dynamism and innovation of the UK's engineering biology companies from 6-9 May in San Jose, California.

06 Mar 24

Press releases

BIA responds to Spring Budget 2024: highlights for UK life sciences

Three highlights for UK life sciences: first, the new expert advisory panel for the HMRC is a smart way to maximise the efficiency of R&D tax relief support for life science innovators; secondly, Alan Marchington’s ICG winning the LIFTs scheme shows real movement to unlock pension funds for life sciences; thirdly, AstraZeneca’s investment in next-generation manufacturing in Speke and Cambridge shows the strength of our ecosystem.

See More

02 May 24

Member news

Infinitopes secures £12.8 million seed financing to enhance its Precision ImmunomicsTM antigen discovery technologies

Infinitopes Precision Immunomics, an integrated cancer biotech combining world-leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the completion of a £12.8 million seed funding round led by Octopus Ventures.

01 May 24

Member news

Poolbeg Pharma plc announces exclusive option agreement to acquire Orphan Drug Candidate for Behçet's Disease

Poolbeg Pharma plc announces that it has entered into an exclusive 12-month option agreement with Silk Road Therapeutics Inc, for a nominal fee, to acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX) for the treatment of oral ulcers in patient's suffering from Behçet's Disease.

See More

Blogs and spotlights

07 May 24

Blog

Paul Freemont's speech on engineering biology at 10 Downing Street reception

Professor Paul Freemont, Faculty of Medicine, Department of Infectious Disease at Imperial College shares insights from his speech at the 10 Downing Street reception. Discover the dynamic landscape of UK engineering biology, where innovation meets sustainability, and explore the vibrant ecosystem of pioneering companies poised to revolutionize industries worldwide.

See More

Latest resources

Here's a selection of featured BIA resources. Explore our Resources Hub

Join us at the next BIA event!

View BIA events I Sector events I Sector Opportunities

Our supporters

hsbc innovation banking.png

JJ_Logo_Stacked_Red_RGB web new.png